Radioactive source materials formable into various shapes

Details Radioactive source materials formable into various shapes Radioactive source materials formable into various shapes

2006-10-10

2006-10-10

Hartley, Michael G. (Department: 1618)

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

C623S001150, C600S003000

Reexamination Certificate

active

07118729

ABSTRACT:
The present invention provides an integral source material, the integral source material has at least one nuclide that is an integral source material having at least one nuclide that is activatable by exposure to radiation, the nuclide is a chemically bound constituent of a polymer of the integral source material, wherein the integral source material is configured before activation to provide a device.

REFERENCES:
patent: 3351049 (1967-11-01), Lawrence
patent: 4323055 (1982-04-01), Kubiatowicz
patent: 4510924 (1985-04-01), Gray
patent: 4702228 (1987-10-01), Russell, Jr. et al.
patent: 4754745 (1988-07-01), Horowitz
patent: 4763642 (1988-08-01), Horowitz
patent: 4891165 (1990-01-01), Suthanthiran
patent: 5079333 (1992-01-01), McGrath et al.
patent: 5163896 (1992-11-01), Suthanthiran et al.
patent: 5199939 (1993-04-01), Dake et al.
patent: 5342283 (1994-08-01), Good
patent: 5354257 (1994-10-01), Roubin et al.
patent: 5405309 (1995-04-01), Carden, Jr.
patent: 5407528 (1995-04-01), McGrath et al.
patent: 5683345 (1997-11-01), Waksman et al.
patent: 5691442 (1997-11-01), Unroe et al.
patent: 5713828 (1998-02-01), Coniglione
patent: 5782740 (1998-07-01), Schneiderman
patent: 5840008 (1998-11-01), Klein et al.
patent: 5840009 (1998-11-01), Fischell et al.
patent: 5863284 (1999-01-01), Klein
patent: 5871436 (1999-02-01), Eury
patent: 5873811 (1999-02-01), Wang et al.
patent: 5894133 (1999-04-01), Armini
patent: 5899882 (1999-05-01), Waksman et al.
patent: 5916143 (1999-06-01), Apple et al.
patent: 5993374 (1999-11-01), Kick
patent: 6152869 (2000-11-01), Park et al.
patent: 6547816 (2003-04-01), O'Foghludha
patent: 2002/0055851 (2002-05-01), Grunze et al.
patent: 19754870 (1998-08-01), None
patent: 19953637 (2001-05-01), None
patent: 2230374 (1974-12-01), None
patent: WO91/02766 (1991-03-01), None
patent: WO97/19724 (1997-06-01), None
patent: WO99/39765 (1999-08-01), None
patent: WO00/29034 (2000-05-01), None
patent: WO00/76557 (2000-12-01), None
Albiero et al., “Short- and Intermediate-Term Results of32P Radioactive β-Emitting Stent Implantantion in Patients with Coronary Artery Disease,”Circulation, 101(1): 18-26 (Jan. 4, 2000).
Carter et al., “Current Status of Radioactive Stents for the Prevention of In-Stent Restenosis,”Int. J. Radiation Oncology Biol. Phys., 41(1): 127-133 (Apr. 1, 1998).
Cheng et al., “Neuron-Activatable Glass Seeds for Brachytherapy,”Journal of Nuclear Medicine, 35(5): 242P (Jun. 1994).
Chettle et al., “Techniques ofin vivoNeutron Activation Analysis,”Phys. Med. Biol., 29(9): 1011-1043 (1984).
Collé, R., “Chemical Digestion and Radionuclidic Assay of TiNi-Encapsulated32P Intravascular Brachytherapy Sources,”Applied Radiation and Isotopes, 50: 811-833 (1999).
European Search Report corresponding to EP03029892 dated Jun. 2, 2004.
Fischell et al., “The Beta-Particle-Emitting Radioisotope Stent (Isostent): Animal Studies and Planned Clinical Trials,”American Journal of Cardiology, 78(3A): 45-50 (1996).
Hausleiter et al., “A New Phosphorus-32 Balloon Catheter Device for Intracoronary Brachytherapy—Results from the Porcine Stent Model,”Journal of the American College of Cardiology, 35(2): 51A (Feb. 2000).
Joensuu et al., “Physical and Biological Targeting of Radiotherapy,”Acta Oncologica Suppl., 13: 72-83 (1999).
Lansky et al., “Patterns of Intimal Heperplasia after32P Brachytherapy: Results from the PREVENT Randomized Clinical Trail,”Circulation, 100(18): I.222-I.223 (Nov. 2, 1999).
Soloway et al., “The Chemistry of Neutron Capture Therapy,”Chem. Rev., 98(4): 1515-1562 (1998).
Wardeh et al., “β-Particle-Emitting Radioactive Stent Implantation,”Circulation, 100(16): 1684-1689 (Oct. 19, 1999).
Yue et al., “Dosimetry Calculation for a Novel Phosphorus-32-Impregnated Balloon Angioplasty Catheter for Intravascular Brachytherapy,”Cardiovascular Radiation Medicine, 1(4): 349-357 (1999).

Affiliated with

Also associated with

Rating

Radioactive source materials formable into various shapes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Radioactive source materials formable into various shapes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radioactive source materials formable into various shapes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3626099